Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
Sarcopenia is common in metastatic colorectal cancer (mCRC), increases the risk of treatment-related toxicity and reduces survival. Trifluridine/tipiracil (TT) chemotherapy significantly improved survival in refractory mCRC patients, but the prognostic and predictive role of pretherapeutic sarcopeni...
Guardado en:
Autores principales: | Mateusz Malik, Maciej Michalak, Barbara Radecka, Marek Gełej, Aleksandra Jackowska, Emilia Filipczyk-Cisarż, Katarzyna Hetman, Małgorzata Foszczyńska-Kłoda, Beata Kania-Zembaczyńska, Danuta Mańka, Marlena Orlikowska, Hanna Rogowska-Droś, Lubomir Bodnar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4d0d1c41af74f5a98c83cefe33c0f6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study
por: Wang X, et al.
Publicado: (2020) -
Activation of the Complement System in Patients with Cancer Cachexia
por: Min Deng, et al.
Publicado: (2021) -
Amelioration of muscle wasting by gintonin in cancer cachexia
por: Yoseph Toni Wijaya, et al.
Publicado: (2021) -
Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data
por: Ana Fernández Montes, et al.
Publicado: (2021) -
Effects of Aerobic Exercise Training on MyomiRs Expression in Cachectic and Non-Cachectic Cancer Mice
por: João Lucas Penteado Gomes, et al.
Publicado: (2021)